This work defines a promising strategy for targeting NLGN3 secretion, which could prove transformative for HGG therapy.
This demonstrated a successful strategy for targeting non-reducing PKS genes with CMeT domains.
Thus, by this study, we propose ODC silencing as a prospective strategy for targeting retinoblastoma.
The applied strategy for targeting drug delivery was based on two mechanisms.
Gene transfer therapy provides a novel strategy for targeting abnormalities in cardiac cells that adversely affect cardiac function.
A promising strategy for targeting VEGF-mediated angiogenesis is RNA interference (RNAi) using short interfering RNA (siRNA).
The engineering of RNA compounds is an effective strategy for targeting conserved functional regions in viral RNA genomes.
A strategy for targeting the hypoxic region of tumors is highly required; however, several issues such as adverse effects and poor penetration property of drugs have hampered developments.
Therefore, we have found and confirmed a novel therapeutic strategy for targeting solid tumors, making use of immune recognition characteristics of γδ T cells.
Protein-based biologics, which leverage the inherent affinity and specificity of protein protein interactions, offer an effective strategy for targeting and modulating disease pathways.
These findings shed light on the regulation of protein PTMs and present a strategy for targeting two modifications with one molecule.
